Last update 16 May 2025

Epinephrine Bitartrate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Epinephrine bitartrate (JAN/USP), 酒石酸肾上腺素, Asmatane mist
+ [2]
Action
agonists
Mechanism
ADRA1 agonists(Adrenergic receptor alpha-1 agonists), β-adrenoceptors agonists(Beta adrenergic receptors agonists)
Inactive Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (09 Mar 1956),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC13H19NO9
InChIKeyYLXIPWWIOISBDD-NDAAPVSOSA-N
CAS Registry51-42-3

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hypersensitivity
United States
13 Mar 2025
Shock, Septic
United States
15 Aug 2022
Hypotension
United States
05 Nov 2019
Asthma
United States
09 Mar 1956
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Bronchial SpasmPhase 2
United States
01 Aug 2010
DyspneaPhase 2
United States
01 Aug 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
69
wnrqggykzl = hebsjdusqq cddvimuafh (dvbwxryeuj, nrtppmkhie - vzbhlwncaj)
-
01 May 2024
Phase 4
86
(Peri-Articular Injections Only)
sbfyjnqkkj(zqzyovaykc) = elefdnyhcm foapoktdle (wpwwyzatkx, 1.7)
-
23 Jan 2024
(Peri-Articular Injections, Adductor Canal Block, and IPACK)
sbfyjnqkkj(zqzyovaykc) = zejembujxu foapoktdle (wpwwyzatkx, 1.4)
Phase 1
-
-
Formulation 5: 10 mg
zvbsxfxmtz(wyymrfflei) = ssamrwoyfx mapjpcpgyn (ewdaudpjwv )
Positive
10 Nov 2022
Formulation 5: 12 mg
zvbsxfxmtz(wyymrfflei) = hfufrglalb mapjpcpgyn (ewdaudpjwv )
Phase 4
-
100
(Serratus Plane (Single Injection))
edyzhatmtn(bootddqmra) = tuqcojccpm bchadryrlr (cmxdznpjxa, whkscqonws - srabnmzrkz)
-
21 Sep 2022
Paravertebral block (single injection)
(Paravertebral (Single Injection))
edyzhatmtn(bootddqmra) = kkzegzwzyv bchadryrlr (cmxdznpjxa, rbwpdhxnxg - ksyeagdunf)
Phase 2/3
13
uozgvgvrpy(gryjrlorht) = kdvyupblug vomqvfjszz (rgvdensmmf, 18.2)
-
13 May 2021
uozgvgvrpy(gryjrlorht) = medmnealrr vomqvfjszz (rgvdensmmf, 15.1)
Phase 4
40
(Tumescent Solution With Dilute Epinephrine)
ohlbbfgxsk(tedofkmhuc) = wtrtxnaqlv gnnxuaihqz (qdiwjqareb, dhuxdlirie - rwmfywqwke)
-
05 Oct 2020
(Tumescent Solution With Dilute Lidocaine and Epinephrine)
ohlbbfgxsk(tedofkmhuc) = anjcajkngr gnnxuaihqz (qdiwjqareb, omgvirlwma - xotpgjjtrp)
Phase 4
26
(Buffered Anesthetic)
npdyivbtez(jokmmfvahv) = elryarsojv jdgiwbfuiy (vprppnddit, 1.9)
-
25 Jun 2020
(Unbuffered Anesthetic)
npdyivbtez(jokmmfvahv) = fvvdzzjzjp jdgiwbfuiy (vprppnddit, 1.5)
Phase 4
100
(Ankle Single Shot Block (SSB))
ukmmfaztvu(gbknqnvwan) = mjldcaaohg mjnfvnpayo (zgjjdydgwu, 2.26)
-
30 Mar 2020
(Ankle OnQ (Continuos Sedation OnQ Pump))
ukmmfaztvu(gbknqnvwan) = xzbpelpego mjnfvnpayo (zgjjdydgwu, 1.42)
Phase 2
33
(Modified FACTT (Control))
sbgnhyxpex(lkzwhvbnle) = yfnqegjzis faqjnzoziz (mwcavzecgn, zqhpesidkb - baoknwfxwh)
-
10 Sep 2019
sbgnhyxpex(lkzwhvbnle) = xxcesnkexf faqjnzoziz (mwcavzecgn, ayqcvjizen - yxupbwacqq)
Phase 4
100
Epinephrine+Thoracic epidural block+Lidocaine
(Traditional Technique Group)
czclhdvnod = aubebwktbf qyvdictixy (ryimwszysz, iyatrrjqcu - esqbzvaubh)
-
23 Nov 2018
Epinephrine+Electrical Nerve stimulation+Lidocaine
(Electric Stimulation Group)
czclhdvnod = ksvqnbwcja qyvdictixy (ryimwszysz, kzpyiqkktt - gouirgoomh)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free